Medicine & Health

WashU Medicine faculty and research members of Siteman Cancer Center have identified a previously unknown population of aggressive tumor cells in difficult-to-treat head and neck cancers.

A WashU Medicine radiologist is on a mission to expand a minimally invasive procedure called cryoablation as a safe option for patients.

WashU Medicine researchers have identified a promising approach to treat myeloproliferative neoplasms, a group of chronic blood cancers, by interfering with a protein that drives inflammation.

A grant to WashU Medicine researchers will fund the study of how inflammation drives myeloproliferative neoplasms, a group of blood cancers at high risk of progressing to acute myeloid leukemia.

Adults with a history of cancer are less likely to be physically active than those without a cancer history, finds a new study from Washington University in St. Louis.

The extent of tumor clearance and timing of treatment are important factors that help improve survival, according to a large analysis of patient outcomes by researchers at WashU Medicine.

WashU Medicine researchers have found that cells originating in bone and normally involved in bone formation are recruited to primary breast tumors, where they become part of the tumor microenvironment and may play a role in supporting tumor growth.

WashU Medicine researchers discovered that while rates of mammography screening remained steady in the overall population over two decades, they fell significantly among younger white women, uninsured women and current smokers.

WashU Medicine researchers have developed a technique to synthesize shape-shifting “disordered proteins,” creating new opportunities to understand the basis of disease and design potential medical interventions.

Biomedical engineers at WashU have created a new platform to study mechanobiology, which can help with research on cancer and fibrosis.